BEE-spoke-data/govdocs1-by-extension huggingface dataset:
**[CONGRESS OF THE UNITED STATES]{.smallcaps}**

**[HOUSE OF REPRESENTATIVES]{.smallcaps}**

**Individual Social Security Investment Program Act of 2005, ISSIPA**

**H.R. 530**

April 2005

-   Benefits remain unchanged for retirees and near retirees over the
    age of 55. Voluntary personal accounts are optional for those age
    21-54. Those under age 21 are only in personal accounts.

-   Individuals deposit their entire 6.2% of salary into their own
    account while the employer's 6.2% of salary is paid into the current
    system for transition financing and to fund the disability and
    widow/orphan programs.

-   Individuals' investment options are diversified bond/stock funds
    like those offered in the federal employee Thrift Savings Plan
    (TSP). After accumulating \$10,000 in an account, a wider range of
    investment options is available through qualified private fund
    managers.

-   A tradable "recognition bond" is issued for past Social Security
    contributions. If traded prior to retirement, proceeds must be
    deposited in the account to grow. Bonds are redeemable from the U.S.
    Treasury on the worker's 67^th^ birthday.

-   The Federal government will guarantee an annuity benefit worth 100%
    of poverty.

-   After purchase of annuity worth 100% of poverty, (self-insuring
    against the government's risk) the worker's annual 6.2%
    contributions could be rebated as cash, making further participation
    voluntary.

-   Those who remain in traditional Social Security would have future
    benefits grow at the rate of inflation, starting in 2013.  

-   The bill has been scored by the Social Security Actuary. The cost of
    doing nothing to the current system is \$10.4 trillion (in today's
    dollars) while the cost of this bill is \$6.8 trillion. This plan
    costs less than any other proposal and puts Social Security
    permanently on sound financial footing starting in 2046.
**DA 06-2515**

December 14, 2006

Leigh S. Willis

Videolink, Inc.

50 Hunt Street

Watertown, MA 02472

Re: Call Sign: E060423 File No.: SES-LIC-20061201-02066

Dear Ms. Willis:

On December 1, 2006, Videolink, Inc. on behalf of Ed Schultz
Broadcasting, LLC filed the above-captioned application for a fixed
earth station to be operated in the Conventional Ku-band.[^1] Pursuant
to Section 25.112(a)(1) of the Commission's rules, 47 C.F.R.
§25.112(a)(1), we dismiss the application as defective without prejudice
to refiling.

The application lists the maximum EIRP density per carrier for emission
24M0G7F as +23.37 dBW/4 KHz. This is less than, and therefore
inconsistent with, the average value of +28.32 dBW/4 kHz that we
calculated using the 66.1 dBW EIRP listed in the application and the
bandwidth of the emission. Given this inconsistency, we cannot determine
the proposed emission power.

Accordingly, pursuant to Section 25.112(a)(1) of the Commission's rules,
47 C.F.R. §25.112(a)(1), and Section 0.261 of the Commission's rules on
delegations of authority, 47 C.F.R. §0.261, we dismiss this application
without prejudice to refiling.[^2]

Sincerely,

Scott A. Kotler

Chief, Systems Analysis Branch

Satellite Division

International Bureau

[^1]: 14.0-14.5 GHz band.

[^2]: If Ed Schultz Broadcasting, LLC refiles a license application
    identical to the one dismissed, with the exception of supplying the
    corrected or missing information, it need not pay an application
    fee. *See* 47 C.F.R. §1.1109(d).
\<Date\>

\<Name\>

\<Title\>

\<Organization\>

\<Address 1\>

\<Address 2\>\
\<City, State, ZIP\>

Dear Prominent Community Leader,

As part of Alcohol Awareness Month activities, the Substance Abuse and
Mental Health Services Administration (SAMHSA) is sponsoring a *Reach
Out Now* National Teach-In during April 2007. This Teach-In is based
upon a two-part set of materials, *Reach Out Now: Talk to Your Fifth
Grader About Underage Alcohol Use* and *Reach Out Now: Talk to Your
Sixth Grader About Underage Alcohol Use*, which will be sent to fifth-
and sixth-grade classroom teachers throughout the Nation. These focus
group-tested materials are designed specifically to foster a dialog
among teachers, parents, and children on underage alcohol use.

SAMHSA's goal is to have *Reach Out Now* Teach-Ins in all 50 States and
the District of Columbia. To date, the First Spouses of \<number\>
States, the Lieutenant Governors of \<number\> States, and more than
\<number\> community-based organizations in \<number\> States and
\<number\> territories plan to participate.

As one of those committed organizations, \<name of your organization\>
is inviting you to consider leading a Teach-In at \<name of school\>
\<during April \_\_\_, 2007\>. We will provide you with a step-by-step
lesson plan and talking points that you can use during the 30-minute
presentation. We also will be coordinating media outreach and providing
supplies, such as \<give examples of what you plan to provide\>.
Experience has shown that *Reach Out Now* Teach-Ins led by prominent
spokespersons encourage broader use of these materials by youth,
teachers, and parents. Prominent spokespersons also can draw increased
media attention to the important public health issue of underage alcohol
use. More information about the National Teach-In and samples of the
*Reach Out Now* materials can be viewed at
[www.teachin.samhsa.gov](http://www.teachin.samhsa.gov/).

If you would like to lead a Teach-In, please contact \<name\>,
\<title\>, \<name of your organization\>, at \<contact information\> no
later than \<state your deadline\>.

We look forward to hearing from you regarding your interest in helping
to keep our children alcohol free.

Sincerely,

\<Name\>

\<Title\>

\<Organization\>

Enclosures
**Table S3.** The genes statistically significantly associated with
tissues of origin. B5, A9, D1, C2, and G5 are, on average, overexpressed
in the melanomas, whereas A3, C3, and A7 are underexpressed in those
cells. B6 is the only gene significantly overexpressed in the CNS cells,
and C7 is the only gene overexpressed in the leukemia. Calculations were
done for the 59 cell lines (excluding NCI/ADR-RES) using a Monte Carlo
permutation t-test.

+-------------+--------------+---------------------------+-------------+
| **          | **Tissue of  | **Mean (**± **SD) in      | **Adjusted  |
| Significant | origin**     | tissue vs.**              | permutation |
| gene**      |              |                           | P value**   |
|             |              | **mean (**± **SD) in the  |             |
|             |              | rest**                    |             |
+-------------+--------------+---------------------------+-------------+
| B5          | ## Melanoma  | 2.8 (± 2.6) vs. -0.6 (±   | \< 0.0001   |
|             |              | 0.7)                      |             |
+-------------+--------------+---------------------------+-------------+
| A9          | Melanoma     | 2.9 (± 2.7) vs. -0.6 (±   | \< 0.0001   |
|             |              | 1.3)                      |             |
+-------------+--------------+---------------------------+-------------+
| D1          | Melanoma     | 2.3 (± 1.8) vs. -0.4 (±   | 0.0005      |
|             |              | 1.4)                      |             |
+-------------+--------------+---------------------------+-------------+
| C2          | Melanoma     | 3.7 (± 2.0) vs. -0.7 (±   | 0.0014      |
|             |              | 2.8)                      |             |
+-------------+--------------+---------------------------+-------------+
| A3          | Melanoma     | -4.3 (± 1.4) vs. 0.8 (±   | 0.0022      |
|             |              | 3.4)                      |             |
+-------------+--------------+---------------------------+-------------+
| G5          | Melanoma     | 0.8 (± 1.0) vs. -0.2 (±   | 0.0215      |
|             |              | 0.7)                      |             |
+-------------+--------------+---------------------------+-------------+
| C3          | Melanoma     | -2.3 (± 1.0) vs. 0.6 (±   | 0.0298      |
|             |              | 2.4)                      |             |
+-------------+--------------+---------------------------+-------------+
| A7          | Melanoma     | -1.2 (± 1.4) vs. 0.2 (±   | 0.0467      |
|             |              | 1.1)                      |             |
+-------------+--------------+---------------------------+-------------+
| B6          | CNS          | 1.4 (± 0.8) vs. -0.1 (±   | 0.0181      |
|             |              | 0.8)                      |             |
+-------------+--------------+---------------------------+-------------+
| C7          | Leukemia     | 3.1 (± 2.6) vs. -0.3 (±   | 0.0239      |
|             |              | 1.9)                      |             |
+-------------+--------------+---------------------------+-------------+
**Instructions for Cane Refiner Agreed-Upon Procedures Engagement**

The cane refiner Agreed Upon Procedures engagement is a two stage
process. First, certain test items are investigated to ensure company's
aggregated electronic records are supported by documentation. Second,
the company's aggregated electronic records are compared to data
submitted to CCC.

**Step 1: Sampling Items**

First, acquire final submissions of form CCC-835 for each of the 12
months during fiscal year 2008 (October 1, 2007 through September 30,
2008). Next, determine the total number of sales invoices or production
days (population) for each test item being evaluated, using internal
electronic company records. Test items are form CCC-835 questions 5 and
9a. For the FY 2008 AUP the sample size is pre-determined, 114 records
from each population. Evaluate each invoice or receipt based on criteria
listed in cells B4 through E4 in the answer sheet workbook. Be sure to
include the unique supporting documentation identifier (i.e. invoice
number, production log number etc.) for each record in the sample.

For example, test item 9a on form CCC-835 is sales for human
consumption. The population for this test item is the total number of
sales invoices for the fiscal year. Randomly draw a sample of 114
invoices from the population. Record responses to questions posed in
cells B4 through E4 of the answer sheet workbook, on the "9a"
spreadsheet. Note, only differences of 1 hundredweight (CWT) or more
should be considered a "miss-match."

Before submitting the workbook to USDA, **BE SURE** the population is
included in cell B3.

**Step 2: Aggregated Items**

Aggregated items are a comparison of company records and data submitted
to CCC. Test items are from CCC-835 questions 1 and 11. First, compare
aggregated company records for each test item with the form CCC-835 data
and evaluate based on the row descriptions for these test items. For
aggregated items, only differences of 10 hundredweights (CWT's) or more
should be considered a "miss-match." A separate "Aggregated" spreadsheet
is included in the answer sheet workbook. Note: USDA requires data to be
submitted hundredweight, raw value (CWT, RV). Company records are likely
to reflect "as made" or hundredweight only (CWT) quantities. Company
personnel can direct you on how to convert CWT to CWT RV, where
necessary.

Upon completion, change the name of the answer sheet to "Cane Refiner
FY08 Answer Sheet -- Your Company Name.xls" and email the final auditors
report and the answer sheet to Francina F. Hentz
(<francina.hentz@wdc.usda.gov>). **Deadline is Thursday, November 20,
2008.**

If you have questions please call Fran Hentz at 202-720-7794.
Tony Tweedale \<ttweed@wildrockies.org\>

04/10/2005 03:42 PM To

Group A-AND-R-DOCKET@EPA

cc

neil_carman@greenbuilder.com, ajs@sagady.com, 4clnair@4cleanair.org,

jpew@earthjustice.org, dbaron@earthjustice.org, DHawkins@nrdc.org,

dcaputo@nrdc.org, tpeel@NYPIRG.org

bcc

Subject

comment, DOCKET ID #OAR-2004-0010; area source Title V exemptions

Re: Public Comment, DOCKET ID \# OAR-2004-0010 (Area source permanent

exemptions from Title V)

Dear EPA:

At the end of Sec. III (General Permits) of the preamble of this

proposed rule, you state: \"\...some states claim that the permiting of

area sources will strain the resources of permitting authorities\...\"

Earlier you repeatedly state that some states claim that about full

Title V permiting for these area sources. Have these states

specifically told you that their resources would be strained if you

required general Title V permits for these area sources? Please be

very clear in responding to the public on this point, as obviously

there is a huge diffrence in permitting agency resources depending on

sources being issued general or full Title V permits.

Much less resource-strain, added to the great toxicity of the HAPs

emmitted by these particular sources, makes your logic in permanently

exempting them shaky. A key determinant would be the accuracy and

precision of compliance monitoring and records.

Thank you for your consideration,

\-\--

Tony Tweedale, MS (Env. Studies)

Secretary, Montana-CHEER (Coalition for Health, Environmental & Economic

Rights)

404 E. Spruce #2, Missoula MT 59802 tel. 406-721-5420 (work)

ttweed@wildrockies.org

The true method of knowledge is experiment (Wlm. Blake 1788), but:

Causality is a concept not subject to empirical demonstration (David
Hume).

Temperate but endangered planet. Enjoys weather, northern lights,

continental drift. Seeks caring relationship with intelligent life form.

-Friends of the Earth
![](media/image1.png){width="4.016666666666667in"
height="0.4201388888888889in"}

![](media/image3.png){width="3.720833333333333in"
height="3.2402777777777776in"}

![](media/image4.png){width="4.277083333333334in" height="0.34375in"}

![](media/image5.png){width="4.170833333333333in"
height="0.32708333333333334in"}

![](media/image6.png){width="4.160416666666666in"
height="0.33402777777777776in"}![](media/image7.png){width="3.657638888888889in"
height="4.927083333333333in"}

![](media/image8.png){width="3.8201388888888888in"
height="2.7805555555555554in"}

![](media/image9.png){width="4.0875in" height="0.38055555555555554in"}

![](media/image10.png){width="4.011111111111111in"
height="0.3277777777777778in"}

![](media/image11.png){width="4.097222222222222in"
height="0.3770833333333333in"}

![](media/image12.png){width="3.917361111111111in"
height="3.2333333333333334in"}![](media/image13.png){width="4.497222222222222in"
height="0.40069444444444446in"}![](media/image14.png){width="1.770138888888889in"
height="3.6840277777777777in"}![](media/image15.png){width="4.1409722222222225in"
height="0.3402777777777778in"}

![](media/image16.png){width="4.0368055555555555in"
height="0.3076388888888889in"}![](media/image17.png){width="4.097222222222222in"
height="0.3638888888888889in"}

![](media/image18.png){width="3.803472222222222in"
height="2.8541666666666665in"}![](media/image19.png){width="3.9305555555555554in"
height="0.3173611111111111in"}

![](media/image20.png){width="4.024305555555555in"
height="0.3541666666666667in"}

![](media/image21.png){width="3.7743055555555554in"
height="2.0743055555555556in"}

![](media/image22.png){width="4.24375in" height="0.33055555555555555in"}
**Investigating the potential for trace metal biosignatures in the rock
record**

Susan L. Brantley

*Earth and Environment Systems Institute*

*The Pennsylvania State University*

*University Park, PA*

*USA*

<brantley@essc.psu.edu>

Laura J. Liermann

*Department of Geosciences*

*The Pennsylvania State University*

*USA*

Elisabeth M. Hausrath

*Department of Geosciences*

*The Pennsylvania State University*

*USA*

Availability of trace elements changed as life evolved, necessitating
the evolution of strategies for targeted metal uptake. If such uptake
occurred and left evidence in the rock record, then trace metal
signatures might document biological activity. For example, Fe is needed
by bacteria, but is often insoluble under oxic conditions. Aerobic
organisms therefore developed siderophores to acquire Fe. Studies
investigating Fe dissolution and isotopic fractionation by
microorganisms have shown promise for detecting biosignatures. For
example, hornblende incubated with a soil bacterium showed an
Fe-depleted layer on the mineral surface, enhanced release of Fe to
solution compared to abiotic conditions, and isotopic fractionation of
dissolved Fe compared to the bulk mineral.

N~2~-fixing microorganisms (diazotrophs) generally require Mo as well as
Fe. Mo may have been less abundant in Archaean and mid-Proterozoic
oceans. An evolutionary advantage might have accrued to organisms that
could produce "molybdophores". Similar to the results for Fe,
experiments have shown that diazotrophs can enhance release of Fe and Mo
from hornblende glass, and may fractionate isotopes of these metals as
well.

In contrast to most organisms, methanogens have a high requirement for
Ni. However, unlike the observations for Fe and Mo, experiments show no
evidence for preferential Ni extraction from minerals. Extraction of Ni
from host rocks by methanogens may therefore not leave any identifiable
trace in rocks. A better understanding of the utilization and uptake of
bioessential metals from host rocks is required to interpret such
potential biosignatures.
Evaluation of Forest Residue Bundling Technology

![](media/image1.jpeg){width="3.0in" height="2.25in"}**ssue:** The
National Fire Plan outlines a coordinated effort to address overstocked
conditions in western forests. A recent inventory found that at least
110 million bdt of non-merchantable biomass (limbs, tops, and
small-diameter stems) could be removed just from high-risk stands. A
significant challenge to recovering non-merchantable material is the
difficulty of handling and transporting many small pieces. Bundling or
baling these residues offers the potential to reduce transport and
handling costs. This technology is currently used in Scandinavia to
recover biomass for energy production. However, there is little
information available on its potential application in western fuel
treatment conditions.

**Study Description:** The objective of this project is to quantify
biomass bundler operation in a range of typical western conditions,
documenting productivity, impacts, and treatment outcomes. Specifically,
the project will examine effects of:

Terrain and site layout (slope and travel distances)

Species (pinyon-juniper, lodgepole pine, firs)

Pre-treatment conditions (scattered logging slash, CTL residuals,
landing piles)

Stand conditions (volume per acre, material size, residual spacings)

The general approach is a series of project case studies. By using the
same machine and operator at all locations, differences would be
specific to the site conditions. Each project site will involve
pretreatment measurements, elemental production study, post-treatment
measurement of effects, and technology transfer through "field day"
demonstration. Bundles produced at various locations will be available
for utilization and samples will be taken to assess energy content.

**Status:** The studies will begin 2003-6-01 in Medford, OR and continue
through the summer.

# Benefits:

# *Improved utilization of forest residues for energy production*

# *Improved transportability of forest residues*

-   *Alternative for areas where prescribed fire is not an option*

**Partners:** John Deere/Timberjack, USDA Forest Service---Forest
Operations Research, Small Diameter Utilization Program, Forest Products
Lab, State and Private Forestry R-1/4, Idaho Panhandle NF, Boise NF,
Deschutes-Ochoco NF, Eldorado NF; Department of Interior Bureau of Land
Management, Medford
District![](media/image2.png){width="0.5319444444444444in"
height="0.5861111111111111in"}
Consultants for

NDAC September 19-20, 2002

All SGEs have been granted voting status unless otherwise noted:

[SGES]{.underline}

[NDAC Consultants:]{.underline}

Eric Brass, M.D., Ph.D.

Chair, Dept. of Medicine

Harbor-UCLA Medical Center

1000 West Carson Street

Torrance, CA 90509

Ralph D'Agostino, Ph.D.

Department of Mathematics

Boston University

111 Cummington Street

Boston, MA 02215

Richard Neill, M.D.

Dept. of Family Practice and Community Medicine

39^th^ and Market St./615 Mutch Building

Philadelphia, PA 19104

Barry Rumack, M.D. (Non-voting)

Univ. of Colorado Health Science Center

33 Silver Fox Circle

Greenwood Village, CO 80121

[Rheumatologists]{.underline}

H. James Williams, M.D. (Only attending on Sept 20)

Department of Internal Medicine

Division of Rheumatology

University of Utah School of Medicine

50 North Medical Drive

Salt Lake City, UT 84132

John Cush, M.D.

Chief of Rheumatology and Clinical Immunology

Presbyterian Hospital

8200 Walnut Hill Lane

Dallas, TX 75231-4496

Janet Elashoff, Ph.D.

Director, Division of Biostatics

Cedars-Sinai Medical Center

8700 Beverly Boulevard

Los Angeles, CA 90048

[Anaesthesiologist]{.underline}

Nathaniel Katz, M.D.

212 Winding Brook Road

New Rochelle, NY 10804

[Hepatologist]{.underline}

Paul B Watkins, M.D. (GI SGE)

Univ. of North Carolina

Chapel Hill, NC 27599

[Nephrologist]{.underline}

Jeffrey Kopp, M.D.

National Institutes of Health

NIDDK, NIH

Building 10/3N116

31 Center Drive

Bethesda, MD 20892-1268

[Gastroenterologist]{.underline}

Laine, Loren, M.D.

Professor of Medicine

Gastrointestinal & Liver Disease Division

LAC 12-137, Department of Medicine

University of Southern California School of Medicine

2025 Zonal Avenue

Los Angeles, California 90033

### Byron Cryer, M.D. 

Associate Professor of Medicine

Division of Gastroenterology

University of Texas Southwestern Medical School

4500 S. Lancaster Road (111B1)

Dallas, TX 75216

[Risk Committee/Epidemiologists]{.underline}

Ruth S. Day, Ph.D.

Duke University

BOX 90085

Durham, NC 27708-0085

Michael R. Cohen, RPh, MS, DSc

Institute for Safe Medication Practices

1800 Byberry Rd, Suite 810

Huntingdon Valley, PA 19006

Stephanie Y. Crawford, Ph.D.

College of Pharmacy, University of Illinois at Chicago

833 S. Wood Street, M/C 871, 258

Chicago, IL 60612

Curt Daniel Furberg, M.D., Ph.D. (Only attending on Sept 19)

Department of Public Health Sciences

Wake Forest University

Medical Center Boulevard, MRI Building

Winston-Salem, NC 27157-1063

[Guest Speaker Consultant for Sept 20,2002 (Non-voting)]{.underline}

Marie R. Griffin, M.D. MPH

Vanderbilt University Medical Center

Department of Preventive Medicine A1124 MCN

Nashville, TN 37232

[Industry representative and Guest (Non-voting)]{.underline}

Michael C. Alfano, D.M.D., Ph.D.,

Dean NYU College of Dentistry\
345 East 24th Street\
New York, NY 10010
Conference, Administrative & Travel Services (CATS)

Monica Sharma, Ph.D., will be coming from India to continue an ongoing
research project in the Laboratory of Neurochemistry, NCPRS under the
supervision of Dr. Harish C. Pant. She will be working on the signaling
mechanisms in neuronal apoptosis. She also will be experimenting on the
involvement of identifying the MAP kinase-1 (MEK-1) as a target of
cdk-5. She will work on understanding how cdk-5 functions at the
molecular level, and phosphorylates substrates like neurofilaments.

She will be here from May 7, 2008 to August 1, 2008.

Dr. Pant has agreed to provide per diem, ground transportation, and a
miscellaneous expense fee.

Request that check be issued to scientist for per diem, miscellaneous
expenses, and ground transportation.

\$4,300.00 perdiem

\$ 600.00 miscellaneous expense

\$ 200.00 for ground transportation

\$5,100.00 TOTAL

The check is to be sent to Linda Franklin, Bldg.10/5N220

Period of contract: May 7, 2008 to August 1, 2008.
**ERISA Advisory Council to Hold Working Group Meetings in July**

**WASHINGTON ---** The 2002 working groups of the Advisory Council on
Employee Welfare and Pension Plans will meet July 17, 18 and 19 to set
their study goals for the year and begin taking testimony on their
respective topics. All sessions, in addition to a 2:00 p.m. full Council
meeting on Friday, July 19, will take place at the U.S. Department of
Labor, 200 Constitution Avenue NW, Washington, DC in Conference Suite
N-5437 A-C.

The working group studying fiduciary education and training will meet
from 9:00 a.m. until approximately 4:30 p.m. on Wednesday, July 17.
Norman Stein, Law Professor at the University of Alabama at Tuscaloosa,
is the working group chair, and Robert Patrician, a Senior Research
Economist for the Communications Workers of America, Washington, DC, is
vice chair.

The working group studying orphan plans will meet from 9:30 a.m. until
approximately 4 p.m. on Thursday, July 18. Orphan plans are plans
abandoned by all plan fiduciaries designated to manage and operate the
plans and their assets. Catherine Heron, Senior Vice President, Fund
Business Management Group, Capital Research and Management in Los
Angeles, Calif., is the working group chair, and David Wray, President
of the Profit Sharing/401(k) Council of Chicago, Ill., is the vice
chair.

The working group studying electronic reporting will meet from 9:30 a.m.
until approximately 1:00 p.m. on Friday, July 19. The chair of the
working group is Evelyn F. Adams, Business Segment Executive, IBM Global
Services, Gaithersburg, Md., and the vice chair is Timothy J. Mahota,
General Counsel, Integral Development, Mountain View, Calif.

At the full Council meeting, the three working group chairs will report
on their groups' progress and members will be updated on activities of
the Pension and Welfare Benefits Administration.

Persons wishing to speak before the various working groups are asked to
contact Sharon Morrissey, the Council's executive secretary, by July 9
at 202-693-8668.

\# \# \#
Dear Sirs:

The VoIP application must not be subject to the current rules and
regulations in place today to manage the public switched telephone
network. To assume that the current patchwork of regulations apply to
voice over the internet applications is a dangerous assumption. VoIP
represents just one example of how the internet can and will generate a
new economic segment within the US economy that will assist our country
in sustaining economic growth well into the future. Extreme caution must
be taken to insure that the states and the Federal Government do not
view internet applications as new sources of tax or fee revenues to
cover current shortfalls in their budgets.

When anything radically new appears the immediate results always are
fear, uncertainty, and doubt. This is the case with VoIP. The
establishment fears the change, they are uncertain about the impacts to
their world, and they doubt that good things will happen for them as a
result. In this environment the desire is to box this radical new thing
into the regulatory confines that exist today. It is just this desire
which must be resisted and questioned.

The US needs new ideas and new economic stimulus to support the American
future. It is new ideas and new technology like voice over the internet
which will support our future generations. The internet is an economic
incubator available to all and it must be allowed to generate new ideas
and deliver new services with as little government intervention as
possible.

You at the FCC and all the fine people assisting you have a very
difficult task in front of you. It is certain that a solution will not
come easily. It is also certain that not everyone will be pleased with
the outcome. I only ask that the decision not be made in haste and that
you base your decisions on the future not the past.

Sincerely Yours,

Doug Black

HDBlack & Co.
**General Schedule Supervisory & EEO Statement**

The incumbent is responsible for expressing ideas and facts to
individuals or groups effectively. This also includes listening to
others, facilitating, exchanging of ideas, and team building.

The incumbent is responsible for motivating and guiding employees,
ensuring staff is appropriately utilized and developed, and adapting
leadership style to various situations.

Provides technical and administrative supervision. Responsible for
making and approving selections for non-supervisory positions and
recommending selections for subordinate supervisory jobs, assigning
duties, reviewing work, approving/disapproving leave and evaluating
performance. Assures equal opportunity is extended to all employees
supervised and all candidates for employment without regard to race,
color, religion, sex, national origin, age or nondisqualifying
handicapping conditions. Assures affirmative implementation of Equal
Employment Opportunity plans of action and applicable Civil Rights
provisions which includes full consideration of eligible minority group
members and women in filling vacant positions; providing career
counseling and orientation; enhancing career opportunities through
training and development, job redesign, and/or similar techniques; and
ensuring full consideration of these employees in recommending
promotions, awards, and other forms of special recognition.

Revised September 2006
URS Environmental Technology & Management Seminar

Topic Category: In Situ Geochemical Fixation of Heavy Metals

Submitted By: Peter Storch, URS Phoenix

In-situ Geochemical Fixation of Chromium in

Groundwater in Arid Climates:

A Comparison of Chemical Reductant Technologies

***Peter Storch*** (Peter_Storch@urscorp.com)

Andrew Messer, and Christopher Lawrence

## URS Corporation, Phoenix, Arizona, USA

URS evaluated case studies for the in-situ treatment of hexavalent
chromium in groundwater in arid or desert environments using geochemical
fixation. In-situ geochemical fixation is the use of a chemical reducing
agent to convert soluble, reactive, toxic hexavalent chromium, Cr(VI),
to insoluble, stable, and non-toxic trivalent chromium, Cr(III). This
paper explores the pros and cons of using different reducing agents
applied via injection points or wells including sodium dithionite,
calcium polysulfide, zero-valent iron, a bioreduction method using
molasses, and a combination organosulfur/lactate reagent for geochemical
fixation of hexavalent chromium. The evaluation begins with a definition
of the criteria for comparison and a brief description of the various
reducing technologies. The technologies were evaluated and compared
using five primary criteria: 1) performance and effectiveness, 2) ease
of implementation, 3) safety, 4) regulatory acceptance, and 5) unit
costs.

Performance and effectiveness were evaluated based on three parameters :
Cr(VI) reduced per mass reductant, success of field demonstrations, and
persistence. To evaluate the ease of implementation, URS compared
factors affecting distribution in the subsurface. These factors include
kinematic viscosity, reaction kinetics, stability, and the ability to
migrate with groundwater. Safety considerations were compared on the
basis of the risk to human health from direct exposure and the risk to
groundwater from byproducts. Typical regulatory concerns, particularly
in a desert environment, include displacement of contaminant and
preferential pathways. Finally, reagent costs were compared in terms of
the cost per mass of Cr(VI) reduced and the reagent cost as a percentage
of total application cost.
**The BERA Asian Pacific American Association and English for Speakers
of Other Languages**

**proudly present**

![](media/image1.jpeg){width="3.65in" height="5.195138888888889in"}

MPAA Rating: R (strong graphic sequences of war violence)

Running Time: 2 hours, 20 minutes

*Brotherhood* tells the dramatic tale of two brothers forced to fight in
the Korean War, and how that conflict lays siege to their family and
friends.

Join us as we watch this outstanding movie from Korean director Kang
Je-gyu!

> **Date: Friday, June 23rd**
>
> **Time: 7:00PM**
>
> **Place: Biology Building 463, Seminar Room (1-57)**
**Session II -- Cereal Science, Whole Grain Foods and Processing --
Poster II-6**

**Protein Changes during Malting of Oats**

Christina Klose^1,2^, Beatus D. Schehl^1,2^, Edith K. Hüttner^1,2^ and
Elke K. Arendt ^1,\*^

^1^Department of Food and Nutritional Sciences, University of Ireland,
Cork, Ireland

^2^BioTransfer Unit, University College Cork, University of Ireland,
Cork, Ireland

\*Corresponding Author: PH: + 353 21 4902064; E-mail:
[[e.arendt@ucc.ie]{.underline}](mailto:e.arendt@ucc.ie)

Malted oat *(Avena sativa)* has been widely used as ingredient for beer
production in medieval times and before. Nowadays oat malt is used in
the brewing industry as flavour adjunct for the production of special
lagers, ales and stouts. Some bakery products can also contain small
amounts of oat malt. Recently oat has received increased interest as
ingredient for functional foods due to its high contents of dietary
fibre, especially β--glucan, as well as minerals and antioxidants. The
objective of this study is to evaluate the protein changes taking place
during malting of oats. The activity of proteolytic enzymes was measured
at various stages during malting. To visualize proteolytic degradation,
proteins of unmalted, germinating and malted seeds were fractionated
based on their solubility. The collected fractions were analysed using a
Lab-on-a-Chip technique, which separates the proteins -- according to
their molecular weight -- by capillary electrophoresis. This new
technique was supported by using two-dimensional gel electrophoresis. In
addition, amino acid analysis was carried out. Overall, proteolytic
activity was found to increase during the malting process. A degradation
of proteins to small peptides and/or amino acids was observed in the
globulin, prolamin and glutelin fractions. As expected, in the albumin
fraction the protein content increased during malting, since this
fraction contains the majority of metabolically active proteins. Amino
acid analysis confirmed the increased protein content in the albumin
fraction and decreased protein content in the other fractions.
Remarkably, in the albumin and glutelin fractions some proteins were
detected, which have not been described in the literature.
![](media/image1.png){width="1.4520833333333334in"
height="1.542361111111111in"}

**1. COMPANY BACKGROUND**

(Year established, position in industry, size, etc.) Word carefully and
briefly (max. 50 words) as the text you provide will be the information
potential business contacts will use to form an opinion about your
company.

**2. Does your product contain at least 51% U.S. content?** Yes No

**3. PRODUCT(S) INFORMATION**

Products to be promoted at this Exhibition. This should include
descriptive language and a mention of significant features --not just
model numbers and names.

**4. OBJECTIVE IN PARTICIPATION**

Please rank Company's top THREE objectives in participating in this show
(1=highest, 3=lowest)

\_\_\_\_ A. Finding a sales representative \_\_\_\_ E. Product
testing/market research

\_\_\_\_ B. Finding licensees \_\_\_\_ F. Obtaining sales leads

\_\_\_\_ C. Finding joint venture partners \_\_\_\_ G. Finding a
distributor

\_\_\_\_ D. Exposure to new business prospects \_\_\_\_ H. Other (please
specify) \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

**5. Are you currently working with a U.S. Export Assistance Center
(USEAC)?** Yes No
**Session VI -- Plant Breeding, Germplasm Utilization and Cereal
Genomics -- Poster VI-18**

**Locating the *Dw6* Dwarfing Locus using NILs**

Stephen J. Molnar\*, Julie Chapados, Bonnie Bancroft and Solomon Kibite
^\#^

Eastern Cereal and Oilseed Research Centre, Agriculture and Agri-Food
Canada, 960 Carling Avenue, Ottawa, Ontario, K1A 0C6, Canada

\# Oat Breeder (deceased), Lacombe Research Centre, Agriculture and
Agri-Food Canada

\* Corresponding Author: PH: (613) 759-1687; E-mail: molnarsj@agr.gc.ca

**Abstract **

In crosses involving multiple height modifying genes, deducing the
genotype of intermediate height plants can be a challenge. Molecular
markers linked to each locus could be used diagnostically in such
situations. We have utilized a set of seven pairs of Near Isogenic Lines
(NILs) (Kibite 2001) to locate the *Dw6* (dwarf) locus to a small
chromosomal region on Kanota x Ogle linkage group 33 (Wight et al.
2003), near Restriction Fragment Length Polymorphism (RFLP) loci
cdo1428b, bcd421b and aco227di. This identified many markers linked to
*Dw6*, which complement those reported by Tanhuanpaa et al. (2006). Such
markers have potential for marker assisted breeding for *Dw6* as well as
for the linked *Pc91* crown rust resistance locus.  Our search strategy
employing targeted mapping with the RFLP probe umn145 since the umn145b
locus was identified by Milach et al. (1997) as linked to *Dw6*. We
incorporated information on umn145 loci reported in published studies
with aneuploids. We also employed comparative mapping with the Terra x
Marion recombinant inbred population (De Koeyer et al. 2004). Whole
genome scanning with Amplified Fragment Length Polymorphism (AFLP)
markers of these *Dw6* NILs as well as a control set of *N1* (naked
seeded) NILs revealed a higher than expected frequency of residual
heterozygosity in the *Dw6* NILs (approximately 5%), but not the *N1*
NILs, of interest to our understanding of the development and genetic
structure of NILs.

De Koeyer, D.L., Tinker, N.A., Wight, C.P., Deyl, J., Burrows, V.D.,
O'Donoughue , L.S., Lybaert, A., Molnar, S.J., Armstrong, K.C., Fedak,
G., Wesenberg, D.M., Rossnagel, B.G., and McElroy, A. 2004. A molecular
linkage map with associated QTLs from a hulless x covered spring oat
population. Theoretical and Applied Genetics 108: 1285-1298.

Kibite, S. 2001. Registration of seven pairs of oat near-isogenic lines,
dwarf vs tall. Crop Sci.41: 277-278.

Milach, S.C.K., Rines, H.W. and Phillips, R.L. 1997. Molecular genetic
mapping of dwarfing genes in oat. Theoretical and Applied Genetics
95:783-790.

Tanhuanpaa, P., Kalendar, R., Laurila, J., Schulman, A., Manninen, O.,
and Kiviharju, E. 2006. Generation of SNP markers for short straw in oat
(*Avena sativa* L.). Genome 49: 282-287.

Wight, C.P., Tinker, N.A., Kianian, S.F., Sorrells, M.E., O'Donoughue,
L.S., Hoffman, D.L., Groh, S., Scoles, G. J., Li, C.D., Webster, F.H.,
Phillips, R.L., Rines, H.W., Livingston, S.M., Armstrong, K.C., Fedak,
G., and Molnar, S.J. 2003. A molecular marker map in Kanota x Ogle
hexaploid oat (*Avena* spp.) enhanced by additional markers and a robust
framework. Genome 46: 28-47.
**§40.163 09/01**

**QUESTION:**

Is it acceptable for an MRO to transmit a number of reports of drug test
results per page to the employer, rather than one per page?

**ANSWER:**

• The Department recommends that MROs use Copy 2 of the CCF as the means
of reporting all drug test results to employers.

• However, if you use a written report (all results) or an electronic
report (negative results) meeting all the requirements of §40.163,
rather than using Copy 2 of the CCF for this purpose, you must put only
one such report on each page. This will help to prevent inadvertent
breaches of confidentiality by the employer resulting from photocopying
a multiple-result report and putting a copy in the file of each employee
involved.

**§40.163 09/01**

**QUESTION:**

If the MRO uses a written report instead of a copy of the CCF to report
results to employers, how should those reports be signed?

**ANSWER:**

> • The MRO must sign all reports of non-negative results (i.e.,
> positives, refusals, tests canceled, and invalids).
>
> • The MRO or an MRO's staff member may rubber stamp and initial
> negative results. The rubber stamp should identify the MRO.

• Each written report should be dated and indicate the address of the
MRO.

**§40.163 01/02**

**QUESTION:**

May the MRO report an "interim" or "preliminary" test result to the
employer (or C/TPA) while awaiting receipt of the MRO copy and/or the
laboratory result?

**ANSWER:**

> • No. An MRO must not report tests results until and unless he or she
> has received all required information from the collection site and
> laboratory.
>
> • This means the MRO must have Copy 2 or a legible copy of Copy 2 (or
> any legible copy of a CCF page signed by the employee) and must have
> the drug test result (sent in the appropriate manners for negatives
> and non-negatives) from the laboratory.
>
> • An MRO sending "in-progress" negative or non-negative results will
> be considered to be in violation of Part 40.
**Position Vacancy Announcement**

The United States Agency for International Development (USAID)
Bangladesh invites applications from Bangladeshi nationals for the
position of Acquisition and Assistance Specialist in the Regional
Acquisition and Assistance Office of USAID/Bangladesh.

The primary purpose of this position is to assist the Senior Acquisition
and Assistance Specialist in providing the whole range of procurement
support for USAID development programs, from inception of awards (i.e.,
contracts; Grants, and Cooperative Agreements), through soliciting,
negotiating and contracting and administering awards, to final closeout
at the end of the program.

**Required Qualifications:**

**1. Education:** A Bachelor\'s Degree or the host-country equivalent.
In absence of a Bachelor\'s Degree, four years of progressively
responsible, job-related, professional-level experience may be
substituted.

**2. Language Proficiency:** Fluency, both written and spoken, is
required in English and Bangla.

**3. Prior Work Experience:** Four years of progressively responsible
experience in procurement or a closely related field. Experience with a
USG agency is desirable.

**4. Knowledge:** General knowledge of U.S. and host-country
acquisition, contracting and business procedures; U.S. and local market
conditions; costs and pricing structures; and negotiation methods and
techniques is desirable. Candidates with knowledge of local labor, tax
and procurement laws will be preferred.

**5. Skills and Abilities**: Ability to organize and manage acquisition
functions effectively. Ability to apply regulations and procedures to
individual situations. Ability to establish and maintain effective
working relations with counterpart levels of USAID, host-government, and
implementing partners. Ability to analyze cost/price data. Ability to
work under pressure. Good oral/written communication skills. This
position also requires good computer skills in order to effectively use
the wide range of job-related computer applications required for this
position.

**If selected, the Applicant must be able to pass security clearance and
health screening for fitness to work. Women and minorities are
encouraged to apply.**

Interested applicants must submit a resume along with a one page cover
letter stating level of education and experience that describes
incumbent's suitability for this position. Please submit to the Human
Resources Section, GPO Box 2593, Ramna, Dhaka-1000**, no later than
December 7, 2005**. Only short-listed candidates will be notified.
![](media/image1.wmf)

**Fourth Annual**

**Veteran's Day**

**Powwow**

**Thursday,**

**November 9, 2006**

**Noon - 10 PM**

**Johnson Center, Dewberry Hall**

**George Mason University**

**Fairfax, VA 22030**

**GRAND ENTRY---1 PM,**

**VETERAN'S HONOR CEREMONY---5 PM**

> **[Northern Drum]{.underline} [Southern Drum]{.underline}**
>
> **White Oak Singers Cedartree Singers**
>
> **[Master of Ceremonies]{.underline} [Arena Director]{.underline}**

**Harry Burk, Lawrence Baker,**

**Arapaho Mandan/Hidatsa**

**[Head Dancers]{.underline}**

**Ashlie Gerard, Cherokee**

**Phil (Waki) Little Thunder, Sicangu Lakota**

Native American music, dancing, art, culture and great food!

**FREE ADMISSION & FREE PARKING!!**

**For more information contact: T Carter, (703) 624-6201**

*Sponsored by the American Indian/Alaskan Native Student Association,
the Office of Diversity Programs & Services, and University Life.*

![](media/image2.png){width="0.38125in" height="0.36319444444444443in"}
![](media/image3.png){width="0.37083333333333335in"
height="0.4097222222222222in"}
![](media/image4.png){width="0.44027777777777777in"
height="0.36736111111111114in"}
![](media/image5.png){width="0.44930555555555557in"
height="0.38263888888888886in"}
# Rye Anther cDNA Library (D-W Choi, TJ Close lab, UC Riverside, 1 May 2000) (SCcDNA0001; SC024E1X)

**Source of RNA:**

-   Plant: Rye (*Secale cereale*. cv Blanco)

-   Type of tissue: anther

-   Growth conditions: from Ed Butler at University of Missouri

-   Total RNA purification: hot phenol method. Nucleic Acid Res (1989)
    17:2362.

-   PolyA purification method: PolyATtrack mRNA Isolation System IV
    (Promega)

-   cDNA synthesis method: cDNA Synthesis Kit (Stratagene)

**Name of vector: Uni-ZAP XR**

\- Uni-ZAP XR vector allows *in vivo* excision of the pBluescript
phagemid

**Description of Inserts:**

-   cDNAs were directionally cloned with *Eco*RI on the 5' and *Xho*I on
    the 3' end

-   cDNAs larger than 0.5 kb were selected by size fractionation via gel
    filtration

**Primary λ Phage Library:**

-   cDNA ligation: 100 ng of cDNA and 1 μg of vector

> \- Packaging: Gigapack III Gold Packaging Extract (Stratagene)

-   Lambda ZAP yield: 2.9 x 10^7^ pfu in 0.5 ml

**Mass Excision Phagemid Library:**

-   Complexity: 1 x 10^6^ λ ZAP pfu (18 μl of primary library) added to
    982 μl SM Buffer

-   Host cells: XL1-Blue-MRF\' (Stratagene), \~ 5 x 10^7^ log-phase
    cells in 1 ml 10 mM MgSO~4~

-   Helper phage: ExAssist (Stratagene), \~1 x 10^9^ pfu; 100 μl

-   Addition of adsorbed mixture of above ingredients to 38 ml LB
    medium, 37°C

-   Mass excision performed for \~3 hrs and centrifuged to create a cell
    pellet and supernatant

-   Supernatant heated at 70°C for 20 min; this is the "Low
    Amplification" library (L).

-   Cell pellet resuspended in 40 ml fresh LB and grown at 37°C for an
    additional 16 \~ 20 hr.

-   Supernatant heated at 70°C for 20 min; this is the "High
    Amplification" library (H).

-   Titered on SOLR (Stratagene) cells:

  ---------------------------- --------------------- --------------------
                               Low Amplification     High Amplification

  Phagemid yield (cfu/ml)      7.0 x 10^5^           1.5 x 10^9^

  Total phagemid yield         2.8 x 10^7^           5.8 x 10^10^
  (cfu/40ml)                                         

  Amplification (cfu/plaque)   28.0                  5.8 x 10^4^

  Percent dark blue colonies   \~ 1.4                \~ 2.8
  ---------------------------- --------------------- --------------------

-   Non-recombinants: 0 of 33 randomly chosen clones contained no insert

-   Insert size distribution:

![](media/image1.wmf)